Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid

Journal of Investigative Dermatology

Volumn 125, Issue 4, 2005, Pages 833-839

  Smits, Tim ^a,b   Robles, Cesar A ^a   Van Erp, Piet E J ^a   Van De Kerkhof, Peter C M ^a   Gerritsen, Marie Jeanne P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

5 ALA; Actinic keratosis; Fluorescence diagnosis; Protoporphyrin IX; Psoriasis

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN; DIAGNOSTIC AGENT; DNA;

ACTINIC KERATOSIS; ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PSORIASIS; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN DEFECT; SPECTROFLUOROMETRY; KERATOSIS; METABOLISM;

AMINOLEVULINIC ACID; DNA; HUMANS; KERATOSIS; PROTOPORPHYRINS; PSORIASIS; SPECTROMETRY, FLUORESCENCE;

EID: 27744459855     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23843.x     Document Type: Article

References (22)

1. Ackermann G, Abels C, Karrer S, Baumler W, Landthaler M, Szeimies RM: Fluorescence-directed biopsy of basal cell carcinomas. Hautarzt 51:920-924, 2000
2. Andersson-Engels S, Berg, Svanberg K, Svanberg S: Multi-colour fluorescence imaging in connection with photodynamic therapy of delta-amino levulinic acid (ALA) sensitised skin malignancies. Bioimaging 3:134-143, 1995
3. Bauer FW, Crombag NHCM, Boezeman JBM, Degrood RM: Flow-cytometry as a tool for the study of cell-kinetics in skin. 2. Cell kinetic data in psoriasis. Br J Dermatol 104:271-276, 1981
4. Bissonnette R, Zeng HS, Mclean DI, Schreiber WE, Roscoe DL, Lui H: Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX. J Invest Dermatol 111:586-591, 1998
5. Caldwell CJ, Hobbs C, Mckee PH: The relationship of Ki67 and involucrin expression in proliferative, pre-neoplastic and neoplastic skin. Clin Exp Dermatol 22:11-16, 1997
6. Ericson MB, Grapengiesser S, Gudmundson F, Wennberg AM, Larko O, Moan J, Rosen A: A spectroscopic study of the photobleaching of protoporphyrin IX in solution. Lasers Med Sci 18:56-62, 2003a
7. Ericson MB, Sandberg C, Gudmundson F, Rosen A, Larko O, Wennberg AM: Fluorescence contrast and threshold limit: Implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B - Biol 69:121-127, 2003b
8. Foley P: Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolg Treat 14 (Suppl. 3):15-22, 2003
9. Fritsch C, Lehmann P, Stahl W, et al: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid. Br J Cancer 79:1603-1608, 1999
10. Fritsch C, Neumann NJ, Ruzicka T, Lehmann P: Photodiagnostic test procedures. Part 3: Fluorescence diagnosis with delta-aminolaevulinic-acid induced porphyrins (FDAP) in dermatology. Hautarzt 51:528-543, 2000
11. Ghadially R, Reed JT, Elias PM: Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107:558-564, 1996
12. Hinnen P, de Rooij FWM, van Velthuysen MLF, et al: Biochemical basis of 5-aminolaevulinic acid induced protoporphyrin IX accumulation: A study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 78:679-682, 1998
13. Inaguma M, Hashimoto K: Porphyrin-like fluorescence in oral cancer - in vivo fluorescence spectral characterization of lesions by use of a near-ultraviolet excited autofluorescence diagnosis system and separation of fluorescent extracts by capillary electrophoresis. Cancer 86:2201-2211, 1999
14. Kennedy JC, Pottier RH, Pross DC: Photodynamic therapy with endogenous protoporphyrin. 9. Basic principles and present clinical-experience. J Photochem Photobiol B - Biol 6:143-148, 1990
15. Krieg RC, Messmann H, Rauch J, Seeger S, Knuechel R: Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem Photobiol 76:518-525, 2002
16. Leunig A, Mehlmann M, Betz C, Stepp H, Arbogast S, Grevers G, Baumgartner R: Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: Fluorescence microscopic studies. J Photochem Photobiol B - Biology 60:44-49, 2001
17. Martin A, Tope WD, Grevelink JM, et al: Lack of selectivity of protoporphyrin-lx fluorescence for basal-cell carcinoma after topical application of 5-aminolevulinic acid - implications for photodynamic treatment. Arch Dermatol Res 287:665-674, 1995
18. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE: Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B - Biol 62:140-145, 2001
19. van de Kerkhof PC, van Rennes H, de Grood R, Bauer FW, Mier PD: Metabolic changes at the margin of the spreading psoriatic lesion. Br J Dermatol 108:647-652, 1983a
20. van de Kerkhof PC, van Rennes H, de Grood RM, de Jongh GJ, Bauer FW, Mier PD: Response of the clinically uninvolved skin of psoriatic patients to standardized injury. Br J Dermatol 109:287-294, 1983b
21. van Erp PE, van de Kerkhof PC: Epidermal calmodulin levels and reference variables. J Invest Dermatol 90:536-537, 1988
22. Wennberg AM, Gudmundson F, Stenquist B, Ternesten A, Molne L, Rosen A, Larko O: In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Derm-Venereol 79:54-61, 1999